Suchergebnisse - "Barlesi, F"

PubPharm (258)

31

Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers : a report from the ESMO Precision Medicine Working Group

enthalten in: Annals of oncology | 24 August 2020

von Mosele, F. | Remon, J. | Mateo, J. | +19

32

Medication Reconciliation Associated with Comprehensive Geriatric Assessment in Older Patients with Cancer: ChimioAge Study

in: Clinical Interventions in Aging | 2020

von Couderc AL | Boisseranc C | Rey D | +8

33

Crizotinib in c-MET- or ROS1-positive NSCLC : results of the AcSé phase II trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Moro-Sibilot, D. | Cozic, N. | Pérol, M. | +21

CommentIn: Ann Oncol. 2020 Mar;31(3):440-441. - PMID 32067689

34

Combinatorial immunotherapy strategies : most gods throw dice, but fate plays chess

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Ciccolini, J. | Barbolosi, D. | André, N. | +2

35

Quantitative mathematical modeling of clinical brain metastasis dynamics in non-small cell lung cancer

enthalten in: Scientific reports | 2019

von Bilous, M. | Serdjebi, C. | Boyer, A. | +6

36

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations : results from the IMMUNOTARGET registry

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Mazieres, J. | Drilon, A. | Lusque, A. | +35

CommentIn: Transl Cancer Res. 2019 Dec;8(Suppl 6):S628-S632. - PMID 35117146

37

Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies

in: Lung Cancer: Targets and Therapy | 2019

von Gadgeel S | Shaw AT | Barlesi F | +10

38

Autoimmune-related bleeding occurring during combined immunotherapy for lung cancer - Case report

enthalten in: Revue des maladies respiratoires | 2018

von Eberst, G. | Lakhzoum, W. | Tomasini, P. | +4

39

Retrospective study of hypersensitivity reactions to chemotherapeutic agents in a thoracic oncology service

enthalten in: Journal of clinical pharmacy and therapeutics | 2018

von Capelle, H. | Tummino, C. | Greillier, L. | +5

CommentIn: J Clin Pharm Ther. 2019 Apr;44(2):335-336. - PMID 30450760

40

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057) : 3-year update and outcomes in patients with liver metastases

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Vokes, E. | Ready, N. | Felip, E. | +23